Company profile: N4 Pharma
1.1 - Company Overview
Company description
- Provider of drug reformulation solutions, developing and out-licensing new versions of existing and novel high-value drugs for unmet needs. Advances products to clinical proof of concept then partners for regulatory. Offerings include Nuvec, a silica nanoparticle system to protect and deliver siRNA, RNA, and DNA; LipTide, a lipid and peptide-based platform that mimics a natural virus for targeted RNA delivery; and ECP105, an siRNA therapy for post-surgical glaucoma by silencing MRTF-B.
Products and services
- ECP105: A siRNA therapeutic targeting post-surgical glaucoma by silencing the fibrotic gene MRTF-B to prevent fibrosis at the surgery site
- LipTide®: A lipid-peptide hybrid delivery system that mimics a natural virus to achieve targeted RNA entry into cells, developed by Nanogenics and acquired by N4 Pharma
- Nuvec®: A silica nanoparticle system engineered to protect and deliver siRNA, RNA, and DNA into cells, offering reduced side effects and improved efficacy versus existing delivery systems
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to N4 Pharma
InnoMedica
HQ: Switzerland
Website
- Description: Provider of patented liposomal nanocarrier drug delivery technology enabling selective, localized transport of active agents to affected areas, improving efficacy and reducing side effects. Offers oncology TLD-1 (Doxorubicin to tumors) and neurology TLN-1 (GM1-Ganglioside across the blood-brain barrier), GMP in-house manufacturing, and a pipeline of liposomal formulations for established and new substances, including RNA or proteins.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InnoMedica company profile →
NaturalNano
HQ: United States
Website
- Description: Provider of proprietary nanomaterials technologies and products, developing unique processes for refining naturally occurring nanotubes and other nanomaterials to add competitive properties to a range of applications; near-term goal to make commercial quantities of high-quality naturally occurring nanotubes, along with licenses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NaturalNano company profile →
NanoH2O
HQ: United States
Website
- Description: Provider of nano-structured enhancements to polymer-based membranes, enabling additional control of key membrane properties and delivering improved throughput at requisite salt and contaminant rejection levels, passive and active fouling resistance, and flexibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoH2O company profile →
California Nanotechnologies
HQ: United States
Website
- Description: Provider of nano-structured components and materials and research and development services, using metallic, ceramic, MMC, and MMNC materials for applications from aerospace to sports & recreation. Offerings include Spark Plasma Sintering (SPS) systems and modeling software, cryogenic milling, hot isostatic pressing (HIP) services, tungsten carbide tooling, and high-strength SPS graphite tooling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full California Nanotechnologies company profile →
Nanostone Water
HQ: United States
Website
- Description: Provider of ceramic and polymeric membrane solutions for industrial process fluid and water treatment. Offers ceramic membrane technology with fouling resistance and high permeability for applications such as municipal drinking water, seawater desalination, municipal wastewater reuse, boiler feed water for power generation, and cooling tower blowdown treatment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanostone Water company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for N4 Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to N4 Pharma
2.2 - Growth funds investing in similar companies to N4 Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for N4 Pharma
4.2 - Public trading comparable groups for N4 Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →